Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
97.48 +1.28    +1.33%
28/02 - Closed. Currency in USD ( Disclaimer )
After Hours
97.02
-0.46
-0.47%
1:59:52 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,929,493
  • Bid/Ask: 96.75 / 97.55
  • Day's Range: 94.35 - 99.22
Moderna 97.48 +1.28 +1.33%

MRNA Income Statement

 
Featured here, the Income Statement (earnings report) for Moderna Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 2811 1831 344 1862
Revenue 2793 1757 293 1828
Other Revenue, Total 18 74 51 34
Cost of Revenue, Total 2335 3401 1879 1923
Gross Profit 476 -1570 -1535 -61
Total Operating Expenses 2805 3843 2211 2228
Selling/General/Admin. Expenses, Total 470 442 332 305
Research & Development 1406 1160 1148 1131
Depreciation / Amortization 4 419 - 78
Interest Expense (Income) - Net Operating -6 -10 -13 -9
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -1404 -1150 -1135 -1122
Operating Income 6 -2012 -1867 -366
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets -22 -37 22 -35
Other, Net -42 -17 -140 -26
Net Income Before Taxes 70 -1958 -1749 -305
Provision for Income Taxes -147 1672 -369 -384
Net Income After Taxes 217 -3630 -1380 79
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 217 -3630 -1380 79
Total Extraordinary Items - - - -
Net Income 217 -3630 -1380 79
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 217 -3630 -1380 79
Dilution Adjustment 3.08 0.93 -0.78 2.05
Diluted Net Income 213.92 -3630.93 -1379.22 76.95
Diluted Weighted Average Shares 395 381 381 405
Diluted EPS Excluding Extraordinary Items 0.542 -9.53 -3.62 0.19
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 0.146 -3.15 -2.91 -0.417
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email